Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE): A Comprehensive Approach and Case Series: Systemic Corticosteroid Therapy Is Necessary in a Large Proportion of Cases

<i>Background and objectives</i>: Acute posterior multifocal pigment epitheliopathy/acute multifocal ischaemic choriocapillaritis (APMPPE/AMIC) is part of the group of choriocapillaritis entities. The aim of this article was to report a series of patients with emphasis on the clinical pr...

Full description

Bibliographic Details
Main Authors: Ioannis Papasavvas, Alessandro Mantovani, Carl P. Herbort
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/58/8/1070
_version_ 1797431962057572352
author Ioannis Papasavvas
Alessandro Mantovani
Carl P. Herbort
author_facet Ioannis Papasavvas
Alessandro Mantovani
Carl P. Herbort
author_sort Ioannis Papasavvas
collection DOAJ
description <i>Background and objectives</i>: Acute posterior multifocal pigment epitheliopathy/acute multifocal ischaemic choriocapillaritis (APMPPE/AMIC) is part of the group of choriocapillaritis entities. The aim of this article was to report a series of patients with emphasis on the clinical presentation and treatment paradigms. <i>Materials and Methods</i>: Retrospective case series study performed in the Centre for Ophthalmic Specialised care (COS), Lausanne, Switzerland, on patients diagnosed from 2000 to 2021 with APMPPE/AMIC. Procedures performed at presentation and upon follow-up (when available) included best corrected visual acuity (BCVA), routine ocular examination, laser flare photometry (LFP) microperimetry (when available) and visual field testing. Imaging investigations included spectral domain optical coherence tomography (SD-OCT)/enhanced depth imaging OCT (EDI-OCT), OCT angiography (OCT-A) as well as fluorescein and indocyanine green angiography (FA, ICGA). The presence or not of prodromal systemic viral-like symptoms was noted. The localisation of lesions whether foveal or extrafoveal, divided the patients into 2 groups (foveal, peri-or parafoveal). Exclusion criteria were patients diagnosed with APMPPE/AMIC and a positive QuantiFERON test and/or VDRL-TPHA tests. <i>Results</i>: Nineteen (35 eyes) of 1664 new patients (1.14%) were diagnosed with APMPPE/AMIC and included in our study. 13 (68%) were male and 6 (32%) were female. The mean age was 33.1 ± 9.2 years. 16 (84%) patients mentioned a viral prodromal episode or other systemic symptoms, and 3 (16%) did not mention any episode before the onset of ocular symptoms. 15 (39%) out of 38 eyes had foveal localisation of the lesions, 20 (52.6%) had peri- or para-foveal localisations and 3 eyes were normal [3 unilateral cases (15%)]. Mean BCVA at presentation was 0.83 ± 0.24 for the whole group. It was 0.58 ± 0.28 for the group with foveal lesions, increasing to 0.97 ± 0.13 at last follow-up (<i>p</i> = 0.0028). For the group with extrafoveal lesions mean BCVA at presentation was 0.94 ± 0.18, improving to 1.18± 0.10 at last follow-up (<i>p</i> = 0.0039). 13 (68%) patients received prednisone treatment, of whom 2 (10%) received additionally at least one immunosuppressive agent, 4 (20%) patients received no treatment and in 2 patients the information was unavailable. All patients in the foveal lesion group received corticosteroid treatment except one who evolved to bilateral macular atrophy. <i>Conclusion</i><i>s</i>: APMPPE/AMIC is a primary choriocapillaritis. Although it is thought that the disease is self-limited, treatment is necessary in most cases, especially when lesions are located in the fovea.
first_indexed 2024-03-09T09:52:54Z
format Article
id doaj.art-7052860f85e34fe7bc5a431d697d59c6
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-09T09:52:54Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-7052860f85e34fe7bc5a431d697d59c62023-12-01T23:58:42ZengMDPI AGMedicina1010-660X1648-91442022-08-01588107010.3390/medicina58081070Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE): A Comprehensive Approach and Case Series: Systemic Corticosteroid Therapy Is Necessary in a Large Proportion of CasesIoannis Papasavvas0Alessandro Mantovani1Carl P. Herbort2Retinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialized Care (COS), Rue Charles-Monnard 6, 1003 Lausanne, SwitzerlandDepartment of Ophthalmology, Valduce Hospital, 22100 Como, ItalyRetinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialized Care (COS), Rue Charles-Monnard 6, 1003 Lausanne, Switzerland<i>Background and objectives</i>: Acute posterior multifocal pigment epitheliopathy/acute multifocal ischaemic choriocapillaritis (APMPPE/AMIC) is part of the group of choriocapillaritis entities. The aim of this article was to report a series of patients with emphasis on the clinical presentation and treatment paradigms. <i>Materials and Methods</i>: Retrospective case series study performed in the Centre for Ophthalmic Specialised care (COS), Lausanne, Switzerland, on patients diagnosed from 2000 to 2021 with APMPPE/AMIC. Procedures performed at presentation and upon follow-up (when available) included best corrected visual acuity (BCVA), routine ocular examination, laser flare photometry (LFP) microperimetry (when available) and visual field testing. Imaging investigations included spectral domain optical coherence tomography (SD-OCT)/enhanced depth imaging OCT (EDI-OCT), OCT angiography (OCT-A) as well as fluorescein and indocyanine green angiography (FA, ICGA). The presence or not of prodromal systemic viral-like symptoms was noted. The localisation of lesions whether foveal or extrafoveal, divided the patients into 2 groups (foveal, peri-or parafoveal). Exclusion criteria were patients diagnosed with APMPPE/AMIC and a positive QuantiFERON test and/or VDRL-TPHA tests. <i>Results</i>: Nineteen (35 eyes) of 1664 new patients (1.14%) were diagnosed with APMPPE/AMIC and included in our study. 13 (68%) were male and 6 (32%) were female. The mean age was 33.1 ± 9.2 years. 16 (84%) patients mentioned a viral prodromal episode or other systemic symptoms, and 3 (16%) did not mention any episode before the onset of ocular symptoms. 15 (39%) out of 38 eyes had foveal localisation of the lesions, 20 (52.6%) had peri- or para-foveal localisations and 3 eyes were normal [3 unilateral cases (15%)]. Mean BCVA at presentation was 0.83 ± 0.24 for the whole group. It was 0.58 ± 0.28 for the group with foveal lesions, increasing to 0.97 ± 0.13 at last follow-up (<i>p</i> = 0.0028). For the group with extrafoveal lesions mean BCVA at presentation was 0.94 ± 0.18, improving to 1.18± 0.10 at last follow-up (<i>p</i> = 0.0039). 13 (68%) patients received prednisone treatment, of whom 2 (10%) received additionally at least one immunosuppressive agent, 4 (20%) patients received no treatment and in 2 patients the information was unavailable. All patients in the foveal lesion group received corticosteroid treatment except one who evolved to bilateral macular atrophy. <i>Conclusion</i><i>s</i>: APMPPE/AMIC is a primary choriocapillaritis. Although it is thought that the disease is self-limited, treatment is necessary in most cases, especially when lesions are located in the fovea.https://www.mdpi.com/1648-9144/58/8/1070primary inflammatory choriocapillaropathies (PICCPs)APMPPE/AMICindocyanine green angiography (ICGA)spectral domain optical coherence tomography (SD-OCT)enhanced depth imaging OCT (EDI-OCT)blue light fundus autofluorescence (BL-FAF)
spellingShingle Ioannis Papasavvas
Alessandro Mantovani
Carl P. Herbort
Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE): A Comprehensive Approach and Case Series: Systemic Corticosteroid Therapy Is Necessary in a Large Proportion of Cases
Medicina
primary inflammatory choriocapillaropathies (PICCPs)
APMPPE/AMIC
indocyanine green angiography (ICGA)
spectral domain optical coherence tomography (SD-OCT)
enhanced depth imaging OCT (EDI-OCT)
blue light fundus autofluorescence (BL-FAF)
title Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE): A Comprehensive Approach and Case Series: Systemic Corticosteroid Therapy Is Necessary in a Large Proportion of Cases
title_full Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE): A Comprehensive Approach and Case Series: Systemic Corticosteroid Therapy Is Necessary in a Large Proportion of Cases
title_fullStr Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE): A Comprehensive Approach and Case Series: Systemic Corticosteroid Therapy Is Necessary in a Large Proportion of Cases
title_full_unstemmed Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE): A Comprehensive Approach and Case Series: Systemic Corticosteroid Therapy Is Necessary in a Large Proportion of Cases
title_short Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE): A Comprehensive Approach and Case Series: Systemic Corticosteroid Therapy Is Necessary in a Large Proportion of Cases
title_sort acute posterior multifocal placoid pigment epitheliopathy apmppe a comprehensive approach and case series systemic corticosteroid therapy is necessary in a large proportion of cases
topic primary inflammatory choriocapillaropathies (PICCPs)
APMPPE/AMIC
indocyanine green angiography (ICGA)
spectral domain optical coherence tomography (SD-OCT)
enhanced depth imaging OCT (EDI-OCT)
blue light fundus autofluorescence (BL-FAF)
url https://www.mdpi.com/1648-9144/58/8/1070
work_keys_str_mv AT ioannispapasavvas acuteposteriormultifocalplacoidpigmentepitheliopathyapmppeacomprehensiveapproachandcaseseriessystemiccorticosteroidtherapyisnecessaryinalargeproportionofcases
AT alessandromantovani acuteposteriormultifocalplacoidpigmentepitheliopathyapmppeacomprehensiveapproachandcaseseriessystemiccorticosteroidtherapyisnecessaryinalargeproportionofcases
AT carlpherbort acuteposteriormultifocalplacoidpigmentepitheliopathyapmppeacomprehensiveapproachandcaseseriessystemiccorticosteroidtherapyisnecessaryinalargeproportionofcases